Quality Solutions That Reduce Compliance Risks in Clinical Trials

Choose from specialized solutions that help you increase quality and efficiency.

Get in Touch
Person on computer running quality assurance check

Why QA Teams Love TransPerfect

Our knowledge and experience in Quality Management is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

    QMS Powered by Trial Interactive

    Our suite of eClinical solutions—part of TransPerfect’s Trial Interactive™ offering—improves visibility, reduces timelines, enhances quality, and mitigates risk. Explore our solutions for quality management, training management, audit management, vendor oversight, quality documents, and more.

    Learn More

    Training and Development

    We offer training support across any platform, in 200+ languages, and any subject matter. Our team centralizes your global learning requirements and manages the administrative work, so you can roll out your content quickly and cost-effectively.

    Learn More

    Language/Translation Solutions

    Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

    Learn More

    Your Partner in Risk Mitigation

    Ensuring quality from R&D through commercialization is complex due to ever-evolving regulations, international policy, and corporate change, among many other variables. QA teams need all the support they can get to embed quality in the organizational culture through efficiencies such as digital and automated work streams, real-time oversight, e-learning, and translated quality documentation for multilingual operations.

    Improved Outcomes by the Numbers

    85% of clinical trials experience delays. Mitigating compliance risks by streamlining QA operations is a key strategy for preventing costly delays caused by CAPAs and inspection findings.

    1.2 M

    Saved by CRAs using our CTMS for day-to-day operations


    7.5 k

    Studies managed in Trial Interactive

    100 +

    TMFs rescued mid-study

    3 k

    eTMF study migrations completed

    50 %

    Faster site activation

    News and Thought Leadership

    Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

    How to Select the Right Regulatory Writing Company for Your Organization's Needs

    In a landscape defined by ever-evolving global guidelines from health authorities, many life sciences organizations’ clinical and regulatory teams face challenges in navigating the regulatory affairs writing and document submission process. Adhering to strict rules while balancing the concerns of multiple stakeholders, timelines, and costs can be a profoundly complex undertaking in this high-stakes environment. To successfully expand their products globally and ...

    How to Select the Right Regulatory Writing Company for Your Organization's Needs

    Governing AI for Global Content in the Life Sciences Industry

    AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and ...

    MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

    As soon as possible, but no later than March 27, 2027 (per MDCG 2026-4), medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their...

    Reddit Stories: AI Failures in Clinical Trials

    Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

    Are Legacy COA Instruments Still Fit for Purpose?

    The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....

    The Human in the Vault: Building Review Workflows That Satisfy Regulators

    AI translation is already fast enough for most teams. The gap is on the review side: who signs off, what gets logged, and whether the process holds up when a regulator asks. This session walks through a real human review workflow within an AI-assisted translation process ...

    eConsent: Why the Content Matters as Much as the Tech

    Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind...

    Trusted by Life Sciences Organizations Big and Small

    Working in QA? Let’s connect.